'Obesema 1 mg injection' Exporter from India to Washington, USA, Zimbabwe & New Zealand
City Drug Exporters specializes in exporting 'Obesema 1 mg injection' from India to international markets including Washington, USA, Zimbabwe, and New Zealand.
We provide dependable supply solutions for pharmaceutical wholesalers, distributors, pharmacies, and healthcare procurement companies.
'Obesema 1 mg injection' is a commonly misheard or misspelled brand name or generic reference for semaglutide-based pre-filled injection pens (such as Obesema, Obeda, or Usema 1 mg) containing semaglutide used for type 2 diabetes and chronic weight management. It is administered subcutaneously once a week
Uses :
Managing blood sugar levels in adults with type 2 diabetes alongside diet and exercise.
Chronic weight management and reducing body fat in obese or overweight adults.
Lowering the risk of major cardiovascular events like heart attacks or strokes in patients with heart disease.
Side Effects :
Nausea, vomiting, diarrhea, or constipation (especially when starting or increasing doses).
Abdominal pain, indigestion, bloating, or gas.
Fatigue and headaches.
Low blood sugar (hypoglycemia), particularly if combined with insulin or sulfonylureas.
Serious risks include pancreatitis, gallbladder problems, or severe allergic reactions.
Precautions :
Do not use if you have a personal or family history of medullary thyroid carcinoma (thyroid cancer) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Inform your doctor if you have a history of pancreatitis, diabetic retinopathy (eye disease), or severe kidney/liver disease.
Avoid use during pregnancy or while breastfeeding unless explicitly prescribed and evaluated by your physician.
Do not share your injection pen with anyone else, even if the needle is changed.
Storage :
Store unused pens in a refrigerator between 2°C and 8°C (36°F to 46°F).
Do not freeze the medication, and do not use it if it has been frozen.
Protect from direct light and excessive heat. Keep out of reach of children.
City Drug Exporters specializes in exporting 'Obesema 1 mg injection' from India to international markets including Washington, USA, Zimbabwe, and New Zealand.
We provide dependable supply solutions for pharmaceutical wholesalers, distributors, pharmacies, and healthcare procurement companies.
'Obesema 1 mg injection' is a commonly misheard or misspelled brand name or generic reference for semaglutide-based pre-filled injection pens (such as Obesema, Obeda, or Usema 1 mg) containing semaglutide used for type 2 diabetes and chronic weight management. It is administered subcutaneously once a week
Uses :
Managing blood sugar levels in adults with type 2 diabetes alongside diet and exercise.
Chronic weight management and reducing body fat in obese or overweight adults.
Lowering the risk of major cardiovascular events like heart attacks or strokes in patients with heart disease.
Side Effects :
Nausea, vomiting, diarrhea, or constipation (especially when starting or increasing doses).
Abdominal pain, indigestion, bloating, or gas.
Fatigue and headaches.
Low blood sugar (hypoglycemia), particularly if combined with insulin or sulfonylureas.
Serious risks include pancreatitis, gallbladder problems, or severe allergic reactions.
Precautions :
Do not use if you have a personal or family history of medullary thyroid carcinoma (thyroid cancer) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Inform your doctor if you have a history of pancreatitis, diabetic retinopathy (eye disease), or severe kidney/liver disease.
Avoid use during pregnancy or while breastfeeding unless explicitly prescribed and evaluated by your physician.
Do not share your injection pen with anyone else, even if the needle is changed.
Storage :
Store unused pens in a refrigerator between 2°C and 8°C (36°F to 46°F).
Do not freeze the medication, and do not use it if it has been frozen.
Protect from direct light and excessive heat. Keep out of reach of children.
Keywords
